HOOKIPA Pharma Inc announced that it has entered into stock purchase agreement with returning investor, Gilead Sciences, Inc. on December 20, 2023. Pursuant to the agreement, the company issued 15,000,000 unregistered shares at an issue price of $1.4167 per share for gross proceeds of $21,250,500 in the transaction. Following the completion of the transaction, the investor's ownership in the company increased to 18,759,465 shares, or approximately 19.4% of the company's outstanding shares.

The company may issue additional unregistered shares of its common Stock with an aggregate value of approximately $8.75 million to the investor. The shares will not be registered under the securities Act of 1933, as amended and the company and the investor have agreed that the issuance of the shares will be accomplished in reliance upon Section 4(a)(2) of the securities Act.